Efficacy of licensed monoclonal antibodies and antiviral agents against the sars-cov-2 omicron sublineages ba.1 and ba.2

HIGHLIGHTS

  • who: Lia Fiaschi and collaborators from the Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy have published the Article: Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2, in the Journal: Viruses 2022, 14, 1374. of 17/06/2022
  • what: The study was approved by the local Ethics Committee and written informed consent was obtained from all the patients enrolled (Neutro-COVID observational study, protocol number 4069/21). The results without the P-gp inhibitor closely matched the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?